Treatment approaches in primary Sjogren syndrome.
Arjan
A
Vissink
Cees G M
CG
Kallenberg
Hendrika
H
Bootsma
D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D000069283:Rituximab; D012464:Saliva, Artificial / Q000627:therapeutic use; D012859:Sjogren's Syndrome / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014987:Xerostomia / Q000188:drug therapy
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D012464:Saliva, Artificial; D000069283:Rituximab